glp-1 colorectal cancer mortality study november 2025 Weight-Loss Meds Linked to Improved Colon Survival GLP-1 receptor agonist initiation and

6.4 IGF-1R tumorigenic interactions with other receptor tyrosine kinases 6.4.1 IGF-1R and FGFR1 axes Manipulating the IGF-1R signaling pathway has been viewed by many scholars as a potential breakthrough in anticancer therapies

The Wegovy stomach paralysis lawsuit alleges that Novo Nordisk, the manufacturer, failed to adequately warn patients about these severe side effects, leading to numerous Ozempic stomach paralysis lawsuits and ongoing litigation

In May 2024, as second study in the New England Journal of Medicine found that the risk of a primary heart or kidney event was 24% lower in the semaglutide group

Disclaimer: We request all readers, electronic media and others follow our citation guidelines when re-posting articles from farmdoc daily

Women who have been on GLP-1 medications should ensure adequate thyroid monitoring during this transition period

Contact us via our support portal: PillSorted Support